RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR rGBM)

Authors: Patrick Wen, Yazmin Odia, Minesh Mehta, Samuel Goldlust, Sharon Tamir, Sharon Shacham, Hongwei Wang, Heidi Sheehan, Kai Li

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa215.813

Source: Full article